Lexicon Pharmaceuticals, Inc.
Price Action
Technical Summary
EMERGING TRENDLexicon Pharmaceuticals, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 78), indicating performance broadly in line with the market. Earnings growth of 53% provides fundamental context to the price action. Investors should exercise caution due to high volatility (85% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.72 | -6.84% | BELOW |
| 50 SMA | $1.66 | -3.49% | BELOW |
| 100 SMA | $1.48 | +8.07% | ABOVE |
| 150 SMA | $1.46 | +9.57% | ABOVE |
| 200 SMA | $1.38 | +15.74% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LXRX in an uptrend right now?
LXRX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is LXRX overbought or oversold?
LXRX's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is LXRX outperforming the market?
LXRX has a Relative Strength (RS) Rating of 78 out of 99. LXRX is performing about average compared to the market.
Where is LXRX in its 52-week range?
LXRX is trading at $1.60, which is 82% of its 52-week high ($1.95) and 76% above its 52-week low ($0.51).
How volatile is LXRX?
LXRX has a Beta of 1.46 and 52-week volatility of 85%. It's more volatile than the S&P 500 - expect bigger swings.